A total of 66% patients developed hypopituitarism as follows: 45% with GH deficiency, 30% with LH/FSH deficiency, 25% with TSH deficiency, 22% with ACTH deficiency and 34% with hyperprolactinemia. This evidence concerns the gene PLOD1 and hyperprolactinemia.